Danish Trade Distributors Stock News

CPSE:SCHO
CPSE:SCHOFood

Schouw & Co. (CPSE:SCHO) Stock Rises On Profit Surge As Margins Stay Thin

Aktieselskabet Schouw went into this report with the stock at DKK680 after a solid run over the past month, and the market is now weighing whether that optimism matches the earnings reality. The headline is clear: Q2 2026 delivered a sharp jump in profitability, with basic earnings per share at DKK14.18 and net income at DKK321m, both well ahead of Q1. In addition, management lifted full year revenue and EBITDA guidance for 2026, which puts the focus firmly on whether this improvement looks...
CPSE:TIV
CPSE:TIVHospitality

Tivoli (CPSE:TIV) Stock Faces Premium Valuation And Softer Profit Trend

Tivoli stock closed at DKK632 after Q2 2026 earnings, roughly flat in recent weeks, yet the numbers behind that calm surface tell a more demanding story. The headline is valuation strain. The shares trade on a P/E of 31.6x while the wider European hospitality industry sits at 18.5x and peers at 14.2x. At the same time, trailing 12 month earnings growth is 1.9% with a net margin of 8.4%. That combination leaves investors paying a clear premium today and raises the question of how much future...
CPSE:VWS
CPSE:VWSElectrical

Vestas Stock Leads 3 Cash Flow Picks Worth Watching Now

Global bond yields have pushed higher as inflation expectations adjust, which has pressured long term rates and made dependable cash flows more valuable in pricing models. When markets focus on macro swings, stocks with solid projected cash generation that also trade below fair value can get overlooked. This article highlights 3 stocks from the Undervalued Stocks Based On Cash Flows screener that stand out on this theme. The 3 stocks highlighted below are just a small sample, since the full...
CPSE:FLS
CPSE:FLSMachinery

Is FLSmidth (CPSE:FLS) Undervalued As Its Service Leadership Change Sharpens Growth Focus?

FLSmidth (CPSE:FLS) stock is back in focus after the company named Petri Virrankoski as President of its Service Business Line, with a planned 2027 start. The appointment underscores attention on the service segment. See our latest analysis for FLSmidth. The leadership news comes at a time when FLSmidth’s recent momentum has been positive. The 1 month share price return is 6.38% and the 1 year total shareholder return is 27.11%. In addition, the 5 year total shareholder return of 155.07%...
CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

What Does Novo Nordisk (CPSE:NOVO B) AI Trial Push Mean For Investors?

Novo Nordisk (CPSE:NOVO B) has entered an AI-focused partnership with H1 to support clinical trial operations. The collaboration uses H1's proprietary AI-ready data and clinical development workflows to support drug development. The agreement is aimed at improving clinical trial design, execution and site or investigator selection through data driven insights. This kind of AI partnership in drug development sits within a wider shift toward digital and data infrastructure. It is worth...
CPSE:NSIS B
CPSE:NSIS BChemicals

Novozymes (CPSE:NSIS B) Launches Optiva Triticum As Valuation Debate Stays In Focus

Novozymes (CPSE:NSIS B) drew fresh attention on 12 August 2026 after Novonesis launched Optiva Triticum, a biosolution designed to give pasta producers more flexibility in wheat sourcing while preserving texture and firmness. See our latest analysis for Novozymes. At a share price of DKK424.6, Novozymes has seen a 12.27% 90 day share price return and a 49.03% three year total shareholder return. This may point to momentum that product launches like Optiva Triticum may be influencing as...
CPSE:MAERSK B
CPSE:MAERSK BShipping

A.P. Møller Mærsk (CPSE:MAERSK B) Lifts Outlook As Investors Ask If The Stock Is Fully Valued

A.P. Møller - Mærsk (CPSE:MAERSK B) just released its second quarter 2026 results, reporting sales of US$15.76b and net income of US$1.26b, alongside an upgraded full year earnings outlook. See our latest analysis for A.P. Møller - Mærsk. The upgraded guidance and earnings beat have coincided with a sharp re‑rating of A.P. Møller - Mærsk, with a 40.9% year to date share price return and a 51.2% one year total shareholder return. This suggests momentum has been building as investors reassess...
CPSE:NKT
CPSE:NKTElectrical

NKT (CPSE:NKT) Stock Can Margin Gains Outrun Cash Flow Strain?

NKT walked into this earnings day with a rich reputation as a high voltage cable pure play and a stock that had cooled in the last quarter, even after a modestly positive 7 day and 30 day run into today’s €966.5 close. The headline is not the top line. Revenue in the latest quarter sat lower than last year, yet operational EBITDA held at €104m and the margin improved to 15.7%. The real story for you is that NKT’s margin engine looked stronger even as project revenue eased. Is NKT now a rare...
CPSE:SOLAR B
CPSE:SOLAR BTrade Distributors

Solar (CPSE:SOLAR B) Stock Faces Margin Strain After Wider Q2 Loss

Solar came into this earnings print with the stock up around 8% over the past month and trading on a rich 53.2x P/E. That is a lot of optimism for a distributor that just reported Q2 revenue of DKK 3.44b and another quarterly loss, with basic earnings per share of DKK 3.4. The sentiment reckoning is simple. Investors have been paying a premium for Solar based on thin trailing margins of 0.3% and a balance sheet carrying interest that earnings do not comfortably cover. Today’s numbers pressure...
CPSE:ORSTED
CPSE:ORSTEDRenewable Energy

Ørsted (CPSE:ORSTED) Stock Hinges On Cash Strength As Profits Retreat

Ørsted stock went into this earnings release under pressure, with the share price down about 14% over the past three months and trading at DKK139.2 at Thursday’s close. The market has been wrestling with an unprofitable trailing year and questions about how the balance sheet will fund a heavy offshore build out. The headline from this quarter is not the income statement. It is the funding capacity. Net debt of DKK22b, a liquidity reserve above DKK115b and a funds from operations to adjusted...
CPSE:BIOMAR
CPSE:BIOMARFood

BioMar Group (CPSE:BIOMAR) Stock Climbs As Record Volumes Meet Softer EPS

BioMar Group walked into this earnings week with a quietly rising share price, up about 9.7% over the past seven days and roughly 3.2% over the past month, which set expectations high. The headline from Q2 is simple: feed volumes reached record levels and earnings before interest and tax guidance lifted to DKK 1.2b to 1.3b for the year. For an aquaculture feed specialist, that guidance shift and the record volumes are what really matter. Short term price excitement now has to be weighed...
CPSE:DNORD
CPSE:DNORDShipping

Dampskibsselskabet Norden (CPSE:DNORD) Stock Faces A Valuation Gap After Profit Surge

Dampskibsselskabet Norden stock went into this earnings print with a modest upward drift over the past week and quarter, yet the headline numbers landed with far more force than the share price suggests. Q2 net profit of US$100.8m and basic earnings per share of US$3.6 put real weight behind the shipping group’s investment story as a cash generative operator. The market now has to square a stock that still trades on a single digit trailing P/E multiple with a quarter that delivered strong...
CPSE:DEMANT
CPSE:DEMANTMedical Equipment

Demant (CPSE:DEMANT), What Is Behind The Fresh Attention?

Demant (CPSE:DEMANT) has drawn fresh investor attention after releasing H1 2026 results showing higher sales and earnings, upgrading its full year outlook, and spotlighting AI powered products such as Oticon Zeal and the newly launched Oticon Reveal. See our latest analysis for Demant. The recent H1 2026 earnings upgrade and the launch of AI powered Oticon Reveal appear to have supported strong momentum in Demant’s share price. The 90 day share price return is 23.83% and the year to date...
CPSE:MAERSK B
CPSE:MAERSK BShipping

Maersk (CPSE:MAERSK B) Stock Priced Richly Despite Sharp Margin Compression

A.P. Møller - Mærsk stock went into this earnings print with a strong run, up about 30% over the past three months and firmly in recovery-story territory. The latest numbers now test that optimism. The headline is profit pressure. Trailing net profit margin sits at 3% compared with 12.6% a year earlier, even as revenue over the last twelve months totals about US$53.6b. The market is weighing a richer P/E of 26.3x against this thinner profitability. This makes this quarter less about volume...
CPSE:ZEAL
CPSE:ZEALBiotechs

Zealand Pharma (CPSE:ZEAL) Stock Can Obesity Progress Outrun Milestone Driven Earnings?

Zealand Pharma stock came into today on a strong run, up 22% over the past month and 10% over three months, with investors leaning into its low 3.7x P/E and fresh profitability over the last year. The earnings release keeps that tension front and center. H1 revenue landed at DKK 4.5b, powered by a DKK 3.7b Phase III milestone and a DKK 798m payment from Roche, and management highlighted DKK 14.5b of cash on hand. The question now is how long that earnings and cash firepower can support the...
CPSE:NETC
CPSE:NETCIT

Netcompany (CPSE:NETC) Stock Growth Momentum Meets A Lingering Margin Squeeze

Netcompany Group stock closed at DKK327.0 on Thursday, with the market already pricing in a high growth story on a P/E of 52.3x. The latest quarter did little to settle the debate over whether that premium represents comfort or a potential cliff edge. Headline revenue for the first half reached DKK4.9b, with organic growth in the mid teens, and management raised full year revenue guidance. The catch lies in profitability. A reported net profit margin of 3.3% for the last year and a recent one...
CPSE:PNDORA
CPSE:PNDORALuxury

Pandora (CPSE:PNDORA) Stock Can Phoenix Offset One Off Margin Support?

Pandora stock has been on a tear, with a roughly 62% gain over the past three months, so expectations were already high coming into this Q2 report. The headline this time is not explosive growth but proof of resilience. Revenue reached DKK 7,219m and basic earnings per share came in at DKK 11.7, while management leaned on margin discipline and a one off tariff refund to keep profitability solid. For investors, the key question now is how that mix of steady top line and supported margins...
CPSE:NETC
CPSE:NETCIT

Is Netcompany Group (CPSE:NETC) Undervalued As Strong Q2 Earnings Lift The Stakes?

Netcompany Group (CPSE:NETC) reported second quarter 2026 earnings on 13 August, with both sales and net income higher than the prior year. The announcement gives investors fresh numbers to reassess the stock. See our latest analysis for Netcompany Group. Netcompany Group's latest earnings update comes after a mixed price pattern, with the share price up 6.2% over the past month yet down 6.4% year to date, while the 1 year total shareholder return of 38.0% and 3 year total shareholder return...